Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Putterman

Showing results (671-680 of 742) with videos related to

Pageof 75
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus ErythematosusRosalind Ramsey-Goldman, Roberta Vezza Alexander, Elena M Massarotti, et al.
Rheumatology (Oxford, England)|June 7, 2018
The SLE-key test serological signature: new insights into the course of lupusChaim Putterman, David S Pisetsky, Michelle Petri, et al.
ACR Open Rheumatology|February 4, 2021
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified LupusRosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, et al.
Arthritis Research & Therapy|January 27, 2018
Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupusSamantha A Chalmers, Jing Wen, Jessica Doerner, et al.
JMIR Pediatrics and Parenting|October 1, 2024
Development of MyREADY Transition BBD Mobile App, a Health Intervention Technology Platform, to Improve Care Transition for Youth With Brain-Based Disabilities: User-Centered Design ApproachAriane Marelli, Ronen Rozenblum, Clara Bolster-Foucault, et al.
Arthritis and Rheumatism|November 16, 2011
Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in miceRahul D Pawar, Milena Pitashny, Simona Gindea, et al.
Journal of Autoimmunity|June 14, 2015
Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritisGuillaume Seret, Felipe Cañas, Laurence Pougnet-Di Costanzo, et al.
Frontiers in Health Services|November 6, 2023
A holistic approach to integrating patient, family, and lived experience voices in the development of the BrainHealth Databank: a digital learning health system to enable artificial intelligence in the clinicJoanna Yu, Nelson Shen, Susan Conway, et al.
Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.
Scientific Reports|May 20, 2016
Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton's Tyrosine KinaseSamantha A Chalmers, Jessica Doerner, Todd Bosanac, et al.
Pageof 75

Showing results (671-680 of 742) with videos related to

Sort By:
Pageof 75
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus ErythematosusRosalind Ramsey-Goldman, Roberta Vezza Alexander, Elena M Massarotti, et al.
Rheumatology (Oxford, England)|June 7, 2018
The SLE-key test serological signature: new insights into the course of lupusChaim Putterman, David S Pisetsky, Michelle Petri, et al.
ACR Open Rheumatology|February 4, 2021
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified LupusRosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, et al.
Arthritis Research & Therapy|January 27, 2018
Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupusSamantha A Chalmers, Jing Wen, Jessica Doerner, et al.
JMIR Pediatrics and Parenting|October 1, 2024
Development of MyREADY Transition BBD Mobile App, a Health Intervention Technology Platform, to Improve Care Transition for Youth With Brain-Based Disabilities: User-Centered Design ApproachAriane Marelli, Ronen Rozenblum, Clara Bolster-Foucault, et al.
Arthritis and Rheumatism|November 16, 2011
Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in miceRahul D Pawar, Milena Pitashny, Simona Gindea, et al.
Journal of Autoimmunity|June 14, 2015
Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritisGuillaume Seret, Felipe Cañas, Laurence Pougnet-Di Costanzo, et al.
Frontiers in Health Services|November 6, 2023
A holistic approach to integrating patient, family, and lived experience voices in the development of the BrainHealth Databank: a digital learning health system to enable artificial intelligence in the clinicJoanna Yu, Nelson Shen, Susan Conway, et al.
Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.
Scientific Reports|May 20, 2016
Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton's Tyrosine KinaseSamantha A Chalmers, Jessica Doerner, Todd Bosanac, et al.
Pageof 75